Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results
11/08/2022 12:33
Aug 11 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES ANNOUNCES FISCAL FIRST QUARTER 2022
FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.11
* STRONG CASH POSITION WITH $54.8 MILLION OF CASH AND CASH
EQUIVALENTS AS OF JUNE 30, 2022
* EXPECTED TO PROVIDE CASH RUNWAY BEYOND AUGUST 2023
Source text for Eikon: ID:nGNX69LDps
Further company coverage: SIOX.O
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results